137 related articles for article (PubMed ID: 37302867)
1. Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society.
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Oct; 46(8):e249-e256. PubMed ID: 37302867
[TBL] [Abstract][Full Text] [Related]
2. [Intraocular pressure elevation and intravitreal steroid implant injection: State of the art in 2023. Recommendations of the French Glaucoma Society and French Ophthalmology Society [French version]].
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Sep; 46(7):803-810. PubMed ID: 37481449
[TBL] [Abstract][Full Text] [Related]
3. Use of selective laser trabeculoplasty as an alternative in patients who developed ocular hypertension after intravitreal dexamethasone implants: a series of 35 eyes.
Billant J; Agard E; Douma I; Levron A; Brunet O; Remignon CH; Sejournet L; Dot C
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3665-3673. PubMed ID: 35665853
[TBL] [Abstract][Full Text] [Related]
4. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
5. [Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
Dot C; El Chehab H; Russo A; Agard E
J Fr Ophtalmol; 2015 Sep; 38(7):656-64. PubMed ID: 26099427
[TBL] [Abstract][Full Text] [Related]
6. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
[TBL] [Abstract][Full Text] [Related]
7. Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
Polski A; Liu KC; Gupta D; Grewal DS; Horns J; Wirostko BM; Stagg BC
BMJ Open Ophthalmol; 2023 Dec; 8(1):. PubMed ID: 38135349
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
10. Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation.
Choi W; Bae HW; Shin HJ; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2022 Aug; 106(8):1150-1156. PubMed ID: 33737305
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience.
Monsellato R; Trovato E; Turchetti P; Forestiere M; Pistone A; De Sio S; Accetta L; Pacella F
Clin Ter; 2020; 170(1):e11-e14. PubMed ID: 31850478
[TBL] [Abstract][Full Text] [Related]
12. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
14. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.
Hemarat K; Kemmer JD; Porco TC; Eaton AM; Khurana RN; Stewart JM
Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):680-685. PubMed ID: 30222802
[TBL] [Abstract][Full Text] [Related]
15. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.
Malclès A; Dot C; Voirin N; Vié AL; Agard É; Bellocq D; Denis P; Kodjikian L
Retina; 2017 Jul; 37(7):1352-1359. PubMed ID: 27768641
[TBL] [Abstract][Full Text] [Related]
16. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
17. Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant.
Baillif S; Staccini P; Weber M; Delyfer MN; Le Mer Y; Gualino V; Collot L; Merite PY; Creuzot-Garcher C; Kodjikian L; Massin P
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365209
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
[TBL] [Abstract][Full Text] [Related]
19. DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors.
Rezkallah A; Kodjikian L; Malclès A; Dot C
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):219-220. PubMed ID: 28801709
[No Abstract] [Full Text] [Related]
20. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
Chin EK; Almeida DRP; Velez G; Xu K; Peraire M; Corbella M; Elshatory YM; Kwon YH; Gehrs KM; Boldt HC; Sohn EH; Russell SR; Folk JC; Mahajan VB
Retina; 2017 Jul; 37(7):1345-1351. PubMed ID: 27806001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
